 This elevation correlates to patient outcome in terms of additional cardiac issues and even mortality within two years.Foreign cfDNA has been shown to be present in the plasma of solid organ transplant patients.This cfDNA is derived from the grafted organ and is termed dd-cfDNA (donor derived cell-free DNA).